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Abstract
Dormant hematopoietic stem cells (HSCs) are activated by microenvironmental cues of the niche in response to the injury of
bone marrow (BM). It is not clearly understood how engrafted cells respond to these cues and are involved in marrow
regeneration. The purpose of this study was to decipher this cellular response in competitive environment. BM cells of
CD45.2 mice were transplanted in sub-lethally irradiated CD45.1 mice. The status of the donor and recipient stem cells (LSK:
Lin2Sca-1+c-Kit+) were determined by flowcytometry using CD45 alleles specific antibodies. The presence of long-term
engraftable stem cells was confirmed by marrow repopulation assay in secondary hosts, and cell cycle status was
determined by staining with Ho33342 and pyronin Y, and BrdU retention assay. The expressions of different hematopoietic
growth factor genes in stromal compartment (CD452 cells) were assessed by real-time reverse transcriptase- polymerase
chain reaction (RT-PCR). The presence of donor cells initially stimulated the proliferation of host LSK cells compared with
control mice without transplantation. This was expected due to pro-mitotic and anti-apoptotic factors secreted by the
donor hematopoietic cells. Upon transplantation, a majority of the donor LSK cells entered into cell cycle, and later they
maintained cell cycle status similar to that in the normal mouse. Donor-derived LSK cells showed 1000-fold expansion within
15 days of transplantation. Donor-derived cells not only regenerated BM in the primary irradiated host for long-term, they
were also found to be significantly involved in marrow regeneration after the second cycle of irradiation. The proliferation of
LSK cells was associated with the onset of colossal expression of different hematopoietic growth factor genes in non-
hematopoietic cellular compartment. Activation of donor LSK cells was found to be dynamically controlled by BM cellularity.
Long-term study showed that a high level of hematopoietic reconstitution could be possible by donor cells in a sub-lethally
irradiated host.
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Introduction
Osteoblastic niche maintains long-term hematopoietic stem cells
(LT-HSCs) in quiescent (G0) state [1–5]. Stem cells remain
attached to the niche cells through many cell surface molecules
[6,7]. Niche protects HSCs from myelo-suppressive stresses.
Dormant or quiescent HSCs are activated and undergo self-
renewal, following asymmetric division of cells, in response to any
stress or stimulation with granulocyte colony-stimulating factor (G-
CSF) [8]. Self-renewal division of HSCs generates a large number
of transiently amplified progenitors and matured cells for
replenishment of the loss of bone marrow (BM) cellularity. Once
marrow regeneration is completed, activated HSCs return back to
dormancy [8].
It has been reported that in response to the combination
treatment of cyclophosphamide (CY) and G-CSF, the endogenous
HSCs proliferate about 10-fold prior to the mobilization in the
peripheral blood [9,10]. In another study, the repopulation ability
of HSCs was shown to be significantly improved by treatment of
mice with G-CSF and stem cell factor (SCF) [11]. The rapid
expansion of HSCs following above treatments suggested that
most of these cells had entered in the cell cycle [9]. In
management of hematological malignancy, often combination of
radiation and chemotherapy is given to the patients, which may
severely affect the hematopoietic system. This may affects other
vital organs also. The hematopoietic system is reconstituted by
transplanting BM cells, especially HSCs. How these donor HSCs
respond to the ablated BM environment is not clearly understood.
Earlier studies showed that in humans as well as in mouse, bone
marrow chimera eventually fails in the long run. This could
happen due to either or combination of (a) rapidly dividing donor
HSCs become defective in engraftment on osteoblastic niche, (b)
osteoblastic niche looses control over donor-HSCs due to
competition with endogenous cells for the space, thus these cells
are engrafted in the vascular niche and slowly egress from the
marrow environment after differentiation, and (c) asymmetric self-
renewal property of donor HSCs is lost. The divisions of LT-HSCs
and short term (ST)-HSCs are considered to be related with the
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cell cycle status, capable of long-term and short-term engraftment
potential, respectively. The quiescent LT-HSCs are responsible for
long-term engraftment; whereas cells exit from the G0 phase (ST-
HSCs/multipotent progenitors) are engrafted for the short-term
[12–14]. The difference between these cells was linked with
marrow homing capacity. However, a recent study showed that
ST-HSCs are also capable for long-term multilineage engraftment
in an irradiated host [15].
In this study, we showed that there is reversibility between
dormancy and proliferation of donor HSCs during marrow
regeneration. In the competitive environment, host cells initially
proliferated; later were found to be compromised in the presence
of highly proliferating donor cells. We also report that mouse BM
stromal cells transiently expressed thousands to million folds of
hematopoietic growth factor genes compared to normal mouse
stromal cells. This induction of growth factor genes was
commenced with the proliferation of HSCs.
Materials and Methods
Animals
Eight- to ten-week-old C57BL/6J [Ptprcb (Ly5.2)] and BL6.SJL
[Ptprcc (Ly5.1)] mice were used in this study. Mice were kept in an
isolator, and fed with autoclaved acidified water and irradiated
food ad libitum. All procedures were approved by the Animal Ethics
Committee (No. 112/07), National Institute of Immunology, New
Delhi, India.
Hematopoietic Reconstitution
BM cells were isolated in two stage process from 6- to 8-week-
old CD45.2 mice. In the first step, cells were removed from tibia
and femurs by flushing with medium. The firmly adhered cells of
the endosteal region were recovered in the second stage by
digesting the crushed bone with collagenase type IV (0.03%) and
dispase enzyme (2 U/ml). BM cells were pooled in a tube and
erythrocytes were lysed by treatment with Gey’s solution [16].
Three different doses (2.5, 5, and 106106 per mice) of cells were
transplanted in sub-lethally (700 cGy) irradiated CD45.1 mice
through lateral tail vein injection. Further, in another experiment
36104 sorted CD45.2LSK cells were transplanted in each mouse,
as above. Sorting of cells was done with a customized FACSAr-
iaIII (BD Biosciences) using 70-mm nozzle. Mice were sacrificed at
different time intervals for analysis.
Competitive Marrow Repopulation Assay
After 10 and 15 days of transplantation, primary (1u) recipients
were sacrificed and BM cells were isolated as described above.
Donor cells (CD45.2) from 1u mice were purified by a one-step
magnetic activated cell sorting (MACS) technique. In brief, BM
cells were incubated with biotinylated CD45.2 antibody (eBios-
ciences, San Diego, CA) for 15 min at 8uC. Excess antibody was
washed out, resuspended cells in MACS buffer were further
incubated with streptavidin microbeads (Miltenyl Biotec, Bergisch,
Gladbach, Germany) for 15 min at 8uC. Finally, washed
magnetically labelled cells were positively sorted in a LS column.
The purity of the cells was determined by negative staining with
anti-CD45.1/PECy5. Four doses (10, 30, 100, 3006103) of sorted
cells were transplanted in the secondary (2u) host (CD45.1). After
30 days of transplantation donor-derived LSK cells were analyzed.
Cell-cell Interaction Study
This study was conducted by both in vitro and in vivo experi-
ments. In vitro experiments were conducted in two ways: (i)
recipient and donor cells were co-cultured (contact) in 6-well
plates, and (ii) cells were cultured by separating them (non-contact)
using 3-mm cell culture insert (Millicell, Millipore Corporation,
Billerica, MA) in 24-well plates. In co-culture experiments, 26106
irradiated (700 cGy) BM cells of CD45.1 mouse were cultured
with same number of unirradiated CD45.2+ cells in 2 ml of
medium (IMDM supplemented with 5% ES-certified FCS). In
control experiments, CD45.2+ cells were not used. In non-contact
experiments, 0.56106/300 ml irradiated CD45.1-mouse BM cells
were taken in the lower chamber, whereas 0.26106/300 ml of
unirradiated CD45.2+ cells were taken on the insert and cultured.
The control experiments were devoid of CD45.2+ cells. After day
1 and 2, cells in the lower chamber were analyzed for apoptosis by
staining with CD45.1 and Annexin V (Apoptosis Detection Kit,
BD Pharmingen) antibodies. Another fraction of cells were fixed
with 4% paraformaldehyde for 30 min, and then permeabilized
using 0.1% saponin. The washed cells were stained with CD45.1
and Ki67 specific antibodies (Santa Cruz Biotechnology, Santa
Cruz, CA) to determine the proliferation of host cells. Finally, the
labelled cells were analyzed with a customized FACSAriaIII (BD
Biosciences) using specific band-pass filters.
In vivo studies were conducted by transplanting 36104 sorted
CD45.2LSK cells in each mouse. Mice without and with
transplantation were sacrificed on day 3, 5 and 10 for analysis of
necrotic (PI staining) and apoptotic (Annexin V staining) cells of
CD45.1LSK compartment. Furthermore, these cells were stained
with anti-cyclin A antibody (Santa Cruz) for immunocytochemical
analysis. Cells were also subjected to real-time RT-PCR analysis
for p21 expression.
Cell Cycle Analysis
Recipient- and Donor-derived LSK cells were subjected to cell
cycle analysis by staining with Hoechst 33342 (Ho) and Pyronin Y
(PY) (Sigma-Aldrich, St Louis) dye [17]. Staining of cells was done
by incubating 16106 cells/500 ml of 1% FCS containing IMDM
with 5 ml Ho dye (1 mg/ml) at 37uC for 1 h. Cells were washed,
resuspended in the same medium and further stained with PY
(1.6 mg/ml) by incubating at 37uC for 1 h. Ho-PY stained cells
were washed twice and labelled for LSK prior to analysis.
BrdU Pulse-chase
Post-transplanted mice were given BrdU pulse for 10 days.
Initially, one injection (100 mg/Kg body weight) was given
through intra-peritoneal route, which was followed by feeding
(1 mg/ml) through drinking water [18]. The pulse was chased for
20 days by feeding normal drinking water to the mice. Mice were
sacrificed at 10 and 30 days of transplantation, BM cells were
harvested and BrdU incorporations in donor and recipient LSK
cells were determined by flow-cytometric analysis. Prior to the
staining, LSK cells were fixed in 4% paraformaldehyde for
30 min, followed by denaturation with 2 N HCl containing 0.5%
Triton X-100 for 15–20 min. Washed cells were stained with anti-
BrdU IgG/FITC antibody (BD Biosciences, San Jose, CA).
Immuno Histochemistry (IHC)
Engraftment of donor stem cells on the endosteal niche was
identified by immunohistochemical analysis. GFP-expressing
crude BM cells were transplanted to 700 cGy irradiated
C57BL6/J mice. After 30 days of transplantation, mice were
sacrificed and tibia and femurs were isolated. Bones were fixed in
4% PFA and decalcified in 5% formic acid. Five micron bone
tissue cryosections were stained with mouse anti-GFP (Clonetech,
CA, Mountain View), mouse osteopontin (Santa Cruz), and anti-
Sca-1 (eBioscience) antibodies. Alexa Fluor 488/594/555 second-
ary antibodies (Molecular Probes, Inc., Eugene, OR) were used to
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identify the specific proteins. The nuclei were stained with 49,6-
diamidino-2-phenylindole (DAPI). Sections were imaged with a
Zeiss LSM 510 META confocal laser-scanning microscope using a
Plan-Apochromat 636/1.4 oil objective. LSM 510 software was
used for acquisition of images. The images were processed by Zeiss
LSM Image browser, version 4.2.0.121.
Flowcytometry
Cells were stained with antibodies Sca-1/FITC, CD45.2/APC,
CD45.1/PECy5, c-Kit/APC (eBisciences), biotinylated lineage
antibody cocktail (Miltenyl), c-Kit/PECy5, Flk2/APC (BD
Pharmingen) for 30 min on ice. Cells were washed three times
with phosphate buffered saline (PBS) containing 0.5% bovine
serum albumin (BSA). The lineage cocktail antibody-stained cells
were further incubated with streptavidin-APCCy7 (BD Pharmin-
gen) for an additional period of 30 min. Washed cells were
analyzed with a customized FACSAriaIII (BD Biosciences) using
specific band-pass filters.
Real-time RT-PCR
The methods for the extraction of total RNA and synthesis of
cDNA are provided in Method S1. Primers for real-time RT-PCR
were designed using Primer Express software version 2.0 (Applied
Figure 1. Proliferation of LSK cells during marrow regeneration. (A) Sub-lethally irradiated mice were maintained (without transplantation)
for different time points. Mice were sacrificed and LSK cells were determined by flowcytometry. Bar diagram shows proliferation kinetics of host BM-
LSK cells (n = 6, each time point); (B) Each sub-lethally irradiated mouse received 106106 crude BM cells of CD45.2 mouse. Mice were sacrificed and
LSK cells were determined by flowcytometry. Bar diagram shows proliferation kinetics of host and donor LSK cells (n = 6, each time point); (C) Each
sub-lethally irradiated mouse received 36104 CD45.2LSK cells. Mice were sacrificed and LSK cells were determined by flowcytometry. Bar diagram
shows proliferation kinetics of host and donor LSK cells (n = 3, each time point); (D, E) Competitive marrow repopulation assay. Donor hematopoietic
(CD45.2+) cells of 10 and 15 days of transplantation were isolated from primary recipient. Four different doses of above sorted cells (106103, 306103,
1006103 and 3006103) were transplanted in 4 groups of mice, each consisting of 4. After 1 month of transplantation, BM cells were isolated from
secondary recipient and analyzed for donor-derived LSK cells. Proportional increase in the recovery of donor LSK with transplantation dose are shown
in E.
doi:10.1371/journal.pone.0050693.g001
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Biosystems, Foster City, CA). The sequences of the primers and
the conditions of the reactions are given in Table S1.
Statistical Analysis
Results of multiple experiments are reported as the mean 6
standard error of the mean (SEM). One-way ANOVA was used to
calculate the significance between the two experimental groups.
Results
Donor Derived LSK Cells are Predominantly Amplified
during Marrow Regeneration
In order to examine the proliferation kinetics of donor-derived
LSK cells and possible competition with that of host, crude BM
cells (CD45.2) were transplanted in irradiated hosts (CD45.1). We
observed increase of LSK cells in BM with the increase of cell dose
(Figure S1). However, early detection of donor LSK cells (within
24 h of transplantation) was made possible at a dose of 106106
cells. Henceforth, all experiments using crude cells were conducted
using the same dose. To study of host cells-derived hematopoiesis
in non-competitive environment (without transplantation), a group
of CD45.1 mice were irradiated and maintained for 2 months.
Mice were sacrificed at different time intervals, and BM cellularity
and total LSK cells were determined. About 120-fold increase of
LSK cells between 3rd and 30th day of irradiation was observed
(Fig. 1A). In contrast, no expansion of host LSK cells was noticed
(with transplantation) after 5th day of transplantation. The
expansion of these cells was prominent only between 1st and 5th
day of transplantation, with 15-fold increase in number (Fig. 1B).
In contrast, the donor-derived LSK cells were steadily increased
up to 15th day of transplantation, about 1000-fold amplification
was observed (Fig. 1B). These results suggest that donor cells, at
the beginning of transplantation induced proliferation of host LSK
cells, which later entered into quiescent stage. To know whether
donor LSK cells serve the same functions as seen in case of crude
cells, we transplanted equivalent number of stem cells (see
materials and methods) and mice were sacrificed at different time
intervals. Analyses of total recovered host and donor LSK cells
showed that the results were comparable with crude donor cells
(Fig. 1B and 1C). The host LSK cells initially showed increase in
number, whereas later 5th day onwards no proliferation was
observed. Interestingly, in this case also donor LSK cells
proliferated till 15th day of transplantation (Fig. 1C).
To ensure that LSK cells are nothing but engraftable HSCs, a
competitive marrow repopulation assay (MRA) was conducted for
CD45.2+ cells, isolated from 1u recipient, in 2u recipients. Initially,
CD45.2+ cells were harvested on 10th and 15th day post-
transplantation from 1u recipients by positive selection method
(Fig. 1D). The sorted cells were transplanted in 2u hosts at four
different doses (10,000 to 300,000 cells per mouse), and
CD45.2LSK cells were analyzed after a month of transplantation.
The purpose of using different doses of cells was to show that with
increase of cell number, HSCs (LSK) populations were propor-
tionately increased and hence the engraftment. Higher the
number of HSCs in 1u hosts greater will be the engraftment and
LSK cells recovery from 2u hosts. It was found that marrow
repopulation, in terms of donor LSK cells, was increased with cell
dose (Fig. 1E). Further, similar trend of results was observed in
samples of both 10th and 15th day, and LSK cells were found to be
several folds higher in the later time point in all 4 doses of cells.
Combining these results, it may be concluded that donor-derived
HSCs were more in number in 15th day than 10th day of
engraftment.
Cell Cycle Activation of Donor LSK Cells is Dynamically
Controlled
In the osteoblastic niche, HSCs are maintained in quiescent (G0)
state. Soon after irradiation, marrow HSCs enter into cell cycle to
reconstitute bone marrow. To determine the kinetics of cell cycle
activation of recipient and donor HSCs and competition between
these cells, if any, respective LSK cells were stained with Ho and
PY. Ho is a DNA inter-chelating dye commonly used for cell cycle
analysis, whereas PY binds with both RNA and DNA. In the
presence of Ho, PY binds specifically with RNA [17]. To know cell
cycle status, crude BM cells were gated for donor- derived LSK
cells (Fig. 2A). Similar gating was also applied for host LSK cells
(not shown). In the G0 state the cellular activity is minimum, which
is increased in the metabolically active (G1) state of the cells. Thus,
Holo-stained diploid LSK cells were divided into two parts, one
that stained low or no with PY (truly representing G0 cells) and the
other that stained high PY (representing G1 cells), as shown in the
contour plot (Fig. 2A, lower right). In irradiated mice (without
transplantation), G0 cells were significantly (p,0.05) dropped to
25.8562.68% (n= 6) within 15 days, before it tend to regain the
normal value (Fig. 2B and 2C). These results confirmed the entry
of host LSK cells into the cycle for proliferation and reconstitution
of hematopoietic system.
In irradiated mice (with transplantation), the situation was
different. The G0 fraction of donor LSK cells was declined and
remained low up to 15th day, which later steadily increased till
the end of the study (Fig. 2D). This was due to competition
between the donor and the host cells in which host cells were
compromised as a result of radiation and/or donor cells
naturally activated as they were removed from their niche.
This was concluded from the cell cycle status of the donor-LSK
cells, in which G0 cells were declined from 87.868.5% (normal
BM) to the lowest values of 2.560.45% (n= 6) in day 10
(Fig. 2D). The activation of donor-HSCs was accompanied by
rapid proliferation of the cells as shown in Figure S2A and S2B.
One most interesting observation made from this study was that
like host, the activity of donor LSK cells might have controlled
by the stem cell niche. Soon after the partial recovery of BM,
donor LSK cells gradually entered into quiescent state, perhaps
by lodging on the osteoblastic niche. Immuno-histochemical
analysis of the trabicular bone confirmed that a good number of
donor-derived stem cells were present near osteoblastic niche
area after 30 days of transplantation (Fig. 3). Overall, it was
surmised that highly proliferating donor LSK cells become
dormant by targeting to the osteoblastic niche.
Transplantation Rescues Host Cells from Apoptosis and
Induces their Proliferation
In the previous experiments, recovery of the host LSK cells in
the initial few days of transplantation was significantly high as
compared to mouse that does not received donor cells. We
hypothesized that donor cells might have some role in this process.
To decipher that, mice with and without transplantation were
sacrificed and host cells (CD45.1LSK) were analyzed to know
relative apoptotic and necrotic cells. Representative dot-plots of
flowcytometry analyses are shown in Figures S3 and S4, and the
compiled data are presented in Table 1. In each of the three times,
percentage apoptotic and necrotic cells was significantly (p,0.001)
declined in case of mice received transplantation. These observa-
tions suggest that donor cells contributed some humeral effect to
host LSK cells for salvaging some of them from undergoing
apoptosis. Further, to confirm relative cell cycle activation in these
cells we analyzed cyclin A and G1/S-check point regulation cyclin-
Self-Renewal Potential of Donor HSCs
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e50693
dependent kinase inhibitor p21cip1/waf1 expressions. The cyclin A
protein was found to be expressed in larger fraction of cells in mice
received transplantation than without the transplantation (Fig. 4A).
This result has been supplemented with p21 mRNA expression,
which declined significantly in case of transplantation (Fig. 4B).
Above studies envisage two specific roles of donor cells: (a)
recovery of host LSK from undergoing apoptosis, and (b)
activation of their proliferation.
In vitro studies were conducted to know whether cell-cell direct
interaction is necessary to confer above protective and proliferative
effects. Irradiated host cells were cultured with direct and indirect
contact of CD45+ donor cells. It may be seen that the proliferation
of host cells was significantly (p,0.001) increased on day 2 of
culture (Table 2) in the presence of donor cells, as more cells
stained for nuclear protein (Ki67). Similarly, apoptotic cells in the
host compartment was significantly (p,0.05) declined on day 1 of
Figure 2. Cell cycle status of LSK cells during marrow regeneration. Cells were stained for LSK, followed by Ho+PY. (A) A representative dot-
plot analysis of the donor cells. Donor-derived LSK cells were selected as follows: donor cells (CD45.2+) were first selected, followed by gating for Sca-
1+c-Kit+ and Lin2 Sca-1+c-Kit+ (LSK) cells. Finally, CD45.2+LSK cells were analyzed for Ho and PY. For recipient cells, instead of CD45.2, cells were
stained with CD45.1 antibody. (B) Bar diagram shows cell cycle status of LSK cells in healthy mice (n = 4); (C) Bar diagram shows cell cycle status of
host LSK cells after irradiation (n = 6, each time point); (D) Bar diagram shows cell cycle status of recipient and donor LSK cells during marrow
regeneration (n = 6, each time point).
doi:10.1371/journal.pone.0050693.g002
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culture in the presence of donor cells, as fewer cells stained for
Annexin V. Further, analysis of the results revealed that direct
cellular contact may not be required for these early beneficial
effects on irradiated host cells as non-contact experiments
performed equally well (Table 2). Overall, results of the above
experiments implicated some soluble factors, secreted by donor
hematopoietic cells, responsible for increase in proliferation of
CD45.1LSK cells in the initial few days of transplantation.
Donor LSK Cells Retain High Proportion of BrdU at 30
Days of Pulse-chase
To confirm that donor stem cells entered much faster in cell
cycle than host, we performed BrdU pulse-chase experiments.
Mice were given long pulse of BrdU for 10 days followed by 20
days of chase. The duration of pulse was maintained long as LT-
HSCs are known to be slowly entered into cell cycle [19]. Results
during pulse showed 6869% donor LSK cells incorporated BrdU,
whereas in the same time only 2064.5% host LSK cells
incorporated the same analogue (Fig. 5, top). These results suggest
that relatively a small fraction of host LSK cells were in the cell
cycle during the period of pulse. This could be due to two possible
reasons: (1) a large fraction of host LSK cells remain in quiescent
state as they adhered on the marrow niche, and/or (2) they
received radiation injury, which prevented entry of cells in to the
S-phase. To know the proportion of BrdU retaining cells in both
the compartments, a 20 days pulse-chase was conducted.
Interestingly, all host and majority of the donor-derived LSK
cells retained BrdU, though a modest dilution effect was noticed in
case of donor LSK cells (Fig. 5, bottom). Furthermore, almost
complete exhaustion of BrdU-LSK cells were observed in both
host and donor compartments during the chase period.
Donor LSK Cells Maintain High Marrow Turnover
Efficiency
In order to show that donor-derived HSCs can maintain
marrow regeneration capacity even after irradiation, we trans-
planted donor cells into sub-lethally irradiated mouse. Donor cells
chimerism was routinely analysed till 7 months of transplantation,
it was 76.466.1% (Figure S7). Further, to confirm the capability of
the donor cells for marrow regeneration, these mice were exposed
to radiation for the second time. After a month, each mouse was
examined for BM chimerism with respect to donor (CD45.2) cells.
All four mice showed high degree (76.867.4%) of donor cells
chimerism (Fig. 6). BM cells were further analyzed for LT-HSCs
and ST-HSCs, results suggested no significant difference (percent)
between donor and host in these two classes of stem cells of
(Table 3). However, significantly (p,0.05) higher number (abso-
lute) of donor-derived stem cells was recovered compared to host
(Table 3).
Hematopoietic Growth Factor Genes are Highly
Expressed in Early Stromal Compartment
The above results prompted us to examine gene expressions of
different hematopoietic growth factors/cytokines that support self-
renewal of HSCs. Since stromal cells express these factors, CD452
cells were sorted from mice at different days of transplantation for
real-time RT-PCR analyses of stem cell factor (SCF), fetal liver
tyrosine kinase ligand (Flt3L), stem cell growth factor (SCGF),
Jagged 2 (Jag2), wingles-type MMTV integration site family
members 3A (Wnt3a) ligand, vascular endothelial growth factor
(VEGF), interleukin-3/6 (IL-3/6) genes. The results showed
similar pattern of expression for above genes, having peak levels
at day 2 and 3 (Fig. 7). After that the expressions of genes were
significantly (p,0.05) reduced from day 5 onwards. These results
probably indicated that high expressions of these growth factors
may not be required after 5 to 10 days of regeneration. Further, it
was revealed that despite stiff decrease of gene expression from day
3, transient amplification of LSK cells continued till day15 of
transplantation (Fig. 1B and Fig. 7).
Discussion
Bone marrow transplantation (BMT) is generally practiced in
cases of non-malignant and malignant hematological disorders
[20]. The purpose of transplantation is to reconstitute/rejuvenate
Figure 3. Donor-derived hematopoietic progenitor cells are
localized in the trabicular bone. Sub-lethally irradiated mice were
transplanted with GFP-expressing crude BM cells. After a month, mice
were sacrificed; longitudinal trabicular bone cryosections (5 mm) were
obtained. Sections were stained for osteopontin (AF594, red), GFP
(AF488, green), Sca-1 (AF555, pink) and nuclei (DAPI, blue). Both
immunofluorescence (composite) and bright filed confocal images are
shown. Arrows indicating donor derived progenitor cells.
doi:10.1371/journal.pone.0050693.g003
Table 1. Anti-apoptotic effect of normal donor cells on irradiated host cells.
Apoptotic CD45.1LSK cells (Annexin V+ in %), m ± sem
Necrotic CD45.1LSK cells
(PI+ in %), m ± sem
Time (days) Without transplantation With transplantation Without transplantation With transplantation
3 26.6062.40* 8.2060.36* 45.6061.70* 28.2061.50*
5 18.0661.30 3.4060.37 46.3061.70 8.7060.60
10 10.9060.58 4.1060.75 8.5060.70 1.2060.14
Significance *p,0.001 *p,0.001
Number of mice in each time point was 3 to 4.
doi:10.1371/journal.pone.0050693.t001
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hematopoietic system for continuous supply of blood lineages and
to induce graft versus leukemic (GVL) reaction (in case of
leukaemia). Though HSC is the major player to induce
physiological changes in the recipients, the cellular environment
is found to play a critical role for engraftment, proliferation and
differentiation of the cells. In the present study we showed that,
under a competitive environment, donor LSK cells proliferate
much rapidly than the host during marrow regeneration. Cell
cycle status suggested that there exist a reversible switch in
regenerating marrow, which induces quiescent stem cells into
actively proliferating state and then bring some of them back into
quiescent state.
Most of the clinical transplantation protocols use high-dose total
body irradiation (TBI) to prevent rejection of the donor graft [21],
to create a condition (by increasing vascular permeability) in which
stem cells are able to home to the BM niches [22,23]. Further,
high dose of TBI allows engraftment of cells by creating more
space in the bone marrow or minimizing competition between
remnant host stem cells and infused donor stem cells [24,25]. Our
earlier study showed that degeneration of stroma can cause poor
retention of donor cells in BM of lethally irradiated mice [26].
Figure 4. Expression of cyclin A and p21cip1/waf1 in CD45.1LSK
cells. (A) Sub-lethally irradiated CD45.1 mice were transplanted with or
without CD45.2LSK Cells. Mice were sacrificed after 3 days of
transplantation and host LSK cells were sorted and immuno- stained
for cyclin A protein. Representative images show that a few cells
expressed cyclin A (arrow) in untransplanted mouse than transplanted
(magnification 606); (B) Host LSK cells of above two groups were
compared for the expression of p21 gene by real time RT-PCR. Bar
diagram shows relative DCt values in two different conditions (n = 3).
doi:10.1371/journal.pone.0050693.g004
Table 2. Effect of normal hematopoietic cells on proliferation and anti-apoptotic effects in irradiated bone marrow cells in culture
(direct or indirect contact).
Proliferation (Ki67+ cells %), m ± sem Apoptosis (Annexin V+ cells %), m ± sem
Direct contact Indirect contact Direct contact Indirect contact
Time (days) W/o donor cells
With donor
cells
W/o donor
cells
With donor
cells
W/o donor
cells
With donor
cells
W/o donor
cells
With donor
cells
0 2.660.10 2.660.10 2.660.10 2.660.10 5.460.25 5.460.25 5.460.25 5.460.25
1 2.460.05 9.160.06 1.660.10 7.560.05 24.564.50* 7.361.45* 19.762.15 8.360.30
2 10.260.15* 20.260.90* 10.560.10 32.060.50 14.361.75 7.561.35 13.060.30 7.861.20
Significance *p,0.001 p,0.001 *p,0.05 p,0.03
Above values were calculated from flowcytometric analyses of respective samples (n = 2 to 3). Representative dot-plots of flowcytometric analyses are shown in Figures
S5 and S6.
doi:10.1371/journal.pone.0050693.t002
Figure 5. Pulse-chase experiment for nuclear incorporation of
BrdU. After transplantation as above, a group of mice were given BrdU
pulse for 10 days (see Materials and Methods), which was followed by
chase for 20 days. First LSK cells were sorted and then stained for BrdU.
The representative histogram (top) show 70.5% of donor (D) and 17.1%
of recipient (R) LSK cells were labelled with BrdU. The representative
histogram (bottom) shows 98% of recipient and 89% of donor cells
retained BrdU. C: Control LSK cells (n = 3).
doi:10.1371/journal.pone.0050693.g005
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Therefore, in this study mice were conditioned by sub-lethal dose
of irradiation. As observed in this study, transient amplification of
host-derived LSK cells within first few days of transplantation was
significantly improved to that in control mice received no graft. In
contrast, at later time points a suppressive effect was seen in host
compartment, probably due to competition between two classes of
cells for the niche, one that was exposed to radiation and the other
not. Interestingly, we showed that soluble factors, secreted by
donor hematopoietic cells, could able to rescue some host cells
undergoing apoptosis and also induce their proliferation. As a
result of that, the net effect was increase in cell number. This was
supported by the expression of two critical cell cycle regulators.
Cyclin A accumulates at the G1/S check point entry, and
associated with cdk2/cdk1 cyclin- dependent kinases [26,27]. It’s
accumulation at the sites of DNA replication suggesting active
involvement in DNA synthesis. The expression of cyclin A in the
larger population of host LSK cells, recovered from the mouse
received transplantation, ensures that donor cells enhanced cell
cycle activation. Irradiation, like several therapeutic agents,
induces DNA damage resulting growth arrest of the cells. In
response to DNA damage, p53 transcriptionally activates the
cyclin-dependent kinase inhibitor p21 and in turn inhibits cell
proliferation for allowing DNA repair [28]. In HSCs, p21
maintains quiescence; conversely decline/absence of p21 has been
marked with the proliferation and increase in absolute number of
cells [29]. The stiff decline in p21 expression suggested that
radiation-exposed host LSK cells might have recovered much
early from DNA repair path and thus experienced faster
Table 3. HSC population in bone marrow after second cycle of irradiation.
HSCs Host LSKFlk2+ cells Host LSKFlk22 cells Donor LSKFlk2+ cells Donor LSKFlk22 cells
% 0.03360.006 0.00860.003 0.16560.042 0.04360.014
Absolute number 14646309* 3316125 2436065446* (p,0.05) 685362278 (p,0.05)
The absolute numbers of HSCs were calculated by multiplying % stem cells with total cells recoverfed.
*,"Significantly higher as compared to the same phenotype of the host cells.
doi:10.1371/journal.pone.0050693.t003
Figure 6. BM donor cells chimerism in irradiated mice. Experiment was initiated as before, after 7 months of transplantation mice were
subjected to second cycle of irradiation and maintained for 1 month. Mice were sacrificed and BM cells were analyzed for chimerism. Representative
dot-plot show 78% donor (CD45.2) cells chimerism (n= 3).
doi:10.1371/journal.pone.0050693.g006
Self-Renewal Potential of Donor HSCs
PLOS ONE | www.plosone.org 8 December 2012 | Volume 7 | Issue 12 | e50693
proliferation in the presence of donor cells than the absence. We
propose that early entry in cell cycle was induced by some soluble
factors secreted by donor cells. At present the identity of these
soluble factors are not know, we speculation that they are different
from the factors secreted by the stromal cells. It is needless to
mention that at least in transcription level stromal-derived factors
were abundant in host compartment. Earlier, it was shown that
human peripheral blood leucocytes conditioned media can
provide protection to rat cardiomyocytes in culture against
necrosis and apoptosis, and a down-stream regulator of Wnt
pathway ‘WISP1’ was one of the factors expressed by the cells
[30]. It was discernable from our preliminary experiments that
WISP1 expresses higher amount in unirradiated than irradiated
cells (data not shown). In a report, normal hematopoietic cells
secreted IL-12 was found to confer cytoprotective effect to HSCs
against irradiation [31].
Other interesting features of this study were enormous
expansion of donor-derived LSK cells and achieving normal
BM cellularity. Previous reports showed that treatment of mice
with CY and G-CSF leads to 10-fold proliferation of
endogenous HSCs, prior to the mobilization of cells in the
peripheral blood [9,10]. This study did not evidence mobiliza-
tion of cells in the peripheral blood (data not shown), despite
massive expansion of stem and progenitor cells was noticed. It
may be remembered that the present study dealt with marrow
regeneration by the engrafted cells, whereas above studies [9,10]
were concerned with egression and mobilization of cells in the
peripheral blood. A competitive marrow repopulation assay was
used for assessment of the functional HSCs in the graft [32].
The results of MRA not only ensured that HSCs amplified in
the primary recipient, but also indicated that they were
enriched in terms of stemness and/or engraftability. For same
dose of transplantation, the recovery of donor’s LSK cells was 3
to 5 folds higher in day 15 than in day 10. This is the first
experimental evidence to demonstrate that symmetric self-
renewal divisions of some donor HSCs might have occurred
to regenerate depleted marrow cells following radiation injury.
Symmetric division of stem cells was reported in other tissues.
For example, in rodent forebrain, increase in symmetric cell
divisions was observed after the stroke [33]. However, it is
generally believed that under steady-state conditions (during
normal physiological processes), stem cells divide asymmetrically.
Quiescent HSCs are maintained in the osteoblastic niche
[1,2]. In the course of asymmetric division they are believed to
come out from the niche, and once the division process is
completed the daughter stem cells return to the niche milieu
[34]. The stiff drop in quiescent (G0) cells with concomitant
increase in G1 and SG2M phase cells suggested that most of the
donor LSK cells were actively proliferating in first 15 days of
transplantation. Later, with increase in BM cellularity, these
cells gradually withdrew from cell cycle and entered in to the
quiescent state. The presence of donor-derived stem/progenitor
cells in the trabicular bone area corroborated this observation.
Earlier it has been shown that host-derived HSCs can enter into
active state from dormancy and vice versa, under the influence
of hematopoietic stress [35]. BrdU is incorporated during DNA
replication; undividing cells consistently retain BrdU in the
nuclei. Since under steady-state conditions stem cells rarely
divide, nuclear retention of BrdU confirms quiescence of the
cells. The results of pulse-chase experiments supported our
earlier notion that majority of the donor-derived LSK cells were
in active proliferation state. Further, it was revealed that both in
the donor and in the recipient compartment a commendable
fraction of LSK cells retained BrdU; these results did not
conclude that all labelled cells were in quiescence state. Despite
a greater fraction of label retaining LSK cells were present in
the host compartment, as compared to that in donor
compartment. The results after the second exposure of
irradiation confirmed that donor LSK cells can confer high
marrow turnover efficiency in this irradiation model.
Marrow regeneration by donor and host stem cells following
irradiation not only depends on the number of short-term and long-
termHSCs, microenvironmental cues also have a pivotal role [36]. On
the basis of microarray results (data not shown), we selected eight
hematopoietic growth factors and cytokines for their gene expressions
in early stage of marrow regeneration. In vitro culture showed that these
factors alone or in combination induces self-renewal of mouse and
human primitive stem and progenitor cells, and also prevents apoptosis
[20,37–40]. Although the expression of gene does not always correlates
with the synthesis of corresponding protein, we assumed that like
Figure 7. Kinetics of gene expression by real time RT-PCR. BM cells were harvested at different time points following irradiation and
transplantation; stromal cells (CD452) were sorted and analyzed for relative (fold) expression of the hematopoietic growth factor genes compared to
that in unirradiated and untransplanted mice. Bar diagrams show fold expressions of mRNAs for different growth factors at days 1, 2, 3, 5 and 15 of
transplantation (n = 3).
doi:10.1371/journal.pone.0050693.g007
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mRNA there may be transient expression of growth factors by the
stromal cells. These results perhaps suggest that the presence of these
growth factors at higher concentrations is required for activation of
stem and progenitor cells. Once cells are activated their fate is decided
by the intrinsic factors. One interesting observation wasmade that stem
cell growth factor (SCGF) gene, previously known as Clec11a, highly
expressed at the initial phase of marrow regeneration along with other
hematopoietic growth factor genes. Earlier studies showed that SCGF
gene was highly expressed in human, rat and mouse stromal cells [41].
Whether SCGF can independently act on primitive stem cells is not
apparent, but this and previous [41] results indicating that it may have
a link with the primitive HSCs. In vitro experiments showed that SCGF
can potentiate the effect of many cytokines for expansion of human
CD34+Lin2 or CD34+CD382 cells [42]. Our study also showed a
differential effect of stromal cells-derived cytokines on donor and host
LSK cells in terms of cellular proliferation and differentiation, the
reason of which is not clearly understood.
BMT is practiced in different routine and in many experimental
therapies. The ultimate success of this therapy is depending on the
long-term hematopoietic reconstitution and negligible or no
GVHD. This study enriches our knowledge on proliferation status
of donor HSCs in a competitive environment. Overall, we
conclude that combination of sub-lethal dose of irradiation and
high dose of donor cells would be beneficial for reconstituting bone
marrow with respect to donor cells.
Supporting Information
Figure S1 Effect of cell dose on the recovery of LSK
cells. Each group of mice were transplanted with three different
doses of cells (2.5, 5.0 to 106106). Donor- and recipient-derived
LSK cells were analyzed after 2 months of transplantation by
flowcytometry. Bar diagram represents the results of 5 animals in
each group.
(TIF)
Figure S2 Distribution of donor, recipient and stromal
cells. Sub-lethally irradiated mice were left untransplanted (A) or
transplanted (B) with crude BM cells (106106/mice). A. Bar
diagram shows distribution of hematopoietic and stromal
compartment of cells. Hematopoietic (CD45.1+) cells and stromal
(CD45.12) cells were analyzed by flowcytrometry. The mean
values were plotted (n = 6); B. Bar diagram shows distribution of
hematopoietic and stromal compartment of cells. Hematopoietic
(CD45.1+, CD45.2+) and stromal (CD45.12CD45.22) cells were
analyzed by flowcytrometry. The mean values were plotted (n = 6).
(TIF)
Figure S3 In vivo cytoprotection of irradiated host cells.
Sub-lethally irradiated mice were left untransplanted (A) or
transplanted (B) with 36104 CD45.2LSK cells. Mice were
sacrificed 3, 5 and 10 days of transplantation and host LSK cells
were analyzed for apoptotic cells by staining with Annexin V.
Representative dot-plots are shown.
(TIF)
Figure S4 In vivo cytoprotection of irradiated host cells.
Sub-lethally irradiated mice were left untransplanted (A) or
transplanted (B) with 36104 CD45.2LSK cells. Mice were
sacrificed 3, 5 and 10 days of transplantation and host LSK cells
were analyzed for necrotic cells by staining with PI. Representative
dot-plots are shown.
(TIF)
Figure S5 In vitro proliferation of irradiated host cells.
Sub-lethally irradiated host (CD45.1) cells were cultured in the
absence (control) or in the presence (test) of unirradiated CD45.2+
cells in contact or without contact. The host cells were analyzed
for Ki67 staining by flowcytomtery.
(TIF)
Figure S6 In vitro cytoprotection of irradiated host
cells. Sub-lethally irradiated host (CD45.1) cells were cultured in
the absence (control) or in the presence (test) of unirradiated
CD45.2+ cells in contact or without contact. The host cells were
analyzed for Annexin V staining by flowcytomtery.
(TIF)
Figure S7 Donor cells chimerism. Mice were transplanted
with 106106 crude donor (CD45.2) cells. Chimerism was
determined seven months of transplantation. Dot-plot analyses
show chimerism of donor (CD45.2) and host (CD45.1) cells for
three mice (n = 3).
(TIF)
Table S1 Real-time primers sequences, amplicon sizes,
annealing temperatures and cycle number of PCR
reactions.
(DOC)
Method S1 Real-time RT-PCR.
(DOCX)
Author Contributions
Conceived and designed the experiments: SKJ AM. Performed the
experiments: SR SJ. Analyzed the data: SR SJ SM AM. Wrote the paper:
SKJ SM AM.
References
1. Gong JK (1978) Endosteal marrow: a rich source of hematopoietic stem cells.
Science 199: 1443–1445.
2. Nilsson SK, Johnston HM, Coverdale JA (2001) Spatial localization of
ransplanted hematopoietic stem cells: inferences for the localization of stem
cell niches. Blood 97: 2293–2299.
3. Zhang J, Niu C, Ye L, Huang H, He X, et al. (2003) Identification of the
haematopoietic stem cell niche and control of the niche size. Nature 425: 836–841.
4. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ (2005) SLAM family
receptors distinguish hematopoietic stem and progenitor cells and reveal
endothelial niches for stem cells. Cell 121: 1109–1121.
5. Wilson A, Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches.
Nature Reviews Immunology 6: 93–106.
6. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, et al. (2004) Tie2/
angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the
bone marrow niche. Cell 118: 149–161.
7. Trumpp A, Essers M, Wilson A (2010) Awakening dormant haematopoietic stem
cells. Nature Reviews Immunology 10: 201–209.
8. Wilson A, Laurenti E, Oser G, vander Wath RC, Blanco BW, et al. (2008)
Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal
during Homeostasis and Repair. Cell 135: 1118–1129.
9. Morrison SJ, Wright DE, Weissman IL (1997) Cyclophosphamide/granulocyte
colony-stimulating factor induces hematopoietic stem cells to proliferate prior to
mobilization. Proc Natl Acad Sci U S A 94: 1908–1913.
10. Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, et al. (2001)
Cyclophosphamide/granulocyte colony-stimulating factor causes selective mo-
bilization of bone marrow hematopoietic stem cells into the blood after M phase
of the cell cycle. Blood 97: 2278–2285.
11. Bodine DM, Seidel NE, Orlic D (1996) Bone marrow collected 14 days after
in vivo administration of granulocyte colony stimulating factor (G-CSF) and
stem cell factor (SCF) to mice has 10 fold more repopulating ability than
untreated bone marrow. Blood 88: 89–97.
12. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, et al. (1993)
Functional heterogeneity is associated with the cell cycle status of murine
hematopoietic stem cells. J Cell Biol 122: 897–902.
13. Gothot A, van der Loo JCM, Clapp DW, Srour EF (1998) Cell cycle–related changes
in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-
obese diabetic/severe combined immune-deficient mice. Blood 92: 2641–2649.
14. Habibian HK, Peters SO, Hsieh CC, Wuu J, Vergilis K, et al. (1998) The
fluctuating phenotype of the lympho hematopoietic stem cell with cell cycle
transit. J Exp Med 188: 393–398.
Self-Renewal Potential of Donor HSCs
PLOS ONE | www.plosone.org 10 December 2012 | Volume 7 | Issue 12 | e50693
15. Liu L, Papa EF, Dooner MS, Machan JT, Johnson KW, et al. (2012) Homing
and long-term engraftment of long- and short-term renewal hematopoietic stem
cells. PLoS One. DOI:10.1371/journal.pone.0031300.
16. Mishell BB, Shiigi SM, Henry C (1980) Preparation of mouse cell suspension. In:
Mishell BB, Shiigi SS, editors. Selected Methods in Cellular Immunology. San
Francisco, CA: WH Freeman. pp. 3–27.
17. Shapiro HM (1981) Flow cytometric estimation of DNA and RNA content in
intact cells stained with Hoechst 33342 and pyronin Y. Cytometry 2: 143–150.
18. Dean PN, Dolbeare F, Gratzner H, Rice GC, Gray JW (1984) Cell-cycle analysis
using a monoclonal antibody to BrdUrd. Cell Tissue Kinet 17: 427–436.
19. Cheshier S, Morrison S, Liao X, Weissman IL (1999) In vivo proliferation and
cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl
Acad Sci U S A 96: 3120–3125.
20. Mukhopadhtay A, Madhusudhan T, Kumar R (2004) Hematopoietic stem cells:
Clinical requirements and developments in ex vivo culture. Adv Biochem Engg/
Biotechnol 86: 215–253.
21. Moore MAS (1997) Stem cell proliferation: Ex vivo and in vivo observations.
Stem Cells 15: 239–248.
22. Cui JS, Wahl RL, Shen TL, Fisher SJ, Recker E, et al. (1999) Bone marrow cell
trafficking following intravenous administration. Br J Haematol 107: 895–902.
23. Shirota T, Tavassoli M (1992) Alterations in bone marrow sinus endothelium
induced by ionizing irradiation: Implications in the homing of intravenously
transplanted marrow cells. Blood Cells 18: 197–214.
24. Stewart FM, Zhong S, Wuu J, Hsieh C, Nilsson SK, et al. (1998)
Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood
91: 3681–3687.
25. Quesenberry PJ, Ramshaw H, Crittenden RB, Stewart FM, Rao S, et al. (1994)
Engraftment of normal murine marrow into nonmyeloablated host mice. Blood
Cells 20: 348–350.
26. Madhusudhan T, Majumdar SS, Mukhopadhyay A (2004) Degeneration of
Stroma Reduces Retention of Homed Cells in Bone Marrow of Lethally
Irradiated Mice. Stem Cells Dev 13: 173–182.
27. Girard F, Strausfeld U, Fernandez A, Lamb NJC (1991) Cyclin A is required for
the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169–1179.
28. Walker DH, Maller JL (1991) Role of cyclin A in the dependence of mitosis on
completion of DNA replication. Nature 354: 314–317.
29. Cheng T, Rodrigues N, Shen H, Yang YG, Dombkowski D, et al. (2000)
Hematopoietic Stem Cell Quiescence Maintained by p21cip1/waf1. Science 287:
1804–1808.
30. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, et al. (2008)
Bone marrow cells are a rich source of growth factors and cytokines: implications
for cell therapy trials after myocardial infarction. Eur Heart J 29: 2851–2858.
31. Chena T, Burkea KA, Zhana Y, Wangb X, Shibatac D, et al. (2007) IL-12
facilitates both the recovery of endogenous hematopoiesis and the engraftment of
stem cells after ionizing radiation. Exp Hematol 35: 203–213.
32. Harrison DE, Jordan CT, Zhong RK, Astle CM (1993) Primitive hematopoiesis
stem cells: Direct assay of most productive populations by competitive
repopulation with simple binomial, correlation and covariance calculations.
Exp Hematol 21: 206.
33. Zhang R, Zhang Z, Zhang C, Zhang Li, Robin A, et al. (2004) Stroke transiently
increases subventricular zone cell division from asymmetric to symmetric and
increases neuronal differentiation in the adult rat. J. Neurosci 24: 5810–5815.
34. Suda T, Arai F, Hirao A (2005). Hematopoietic stem cells and their niche.
Trends Immunol 26: 426–433.
35. Arai F, Suda T (2007) Regulation of hematopoietic stem cells in the osteoblastic
niche; Annals of the New York Academy of Sciences 1176: 36–46.
36. Veiby P, Jacobsen FW, Cui L, Lyman SD, Jacobsen SEW (1996) The Flt3
Ligand Promotes the Survival of Primitive Hemopoietic Progenitor Cells with
Myeloid as Well as B Lymphoid Potential Suppression of Apoptosis and
Counteraction by TNFa and TGFb. J Immunol 157: 2953–2960.
37. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoeman R (1992) Role of c-kit
ligand in the expansion of human hematopoietic progenitor cells. Blood 79: 634–
641.
38. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, et al. (1993) Interleukin-11
stimulates the proliferation of human hematopoietic CD34+ and CD34+CD332
DR2 cells and synergizes with stem cell factor, interleukin-3, and granulocyte-
macrophage colony-stimulating factor. Exp Hematol 21: 1668–1672.
39. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M (1996) Thrombo-
poietin supports proliferation of human primitive hematopoietic cells in synergy
with steel factor and/or interleukin-3. Blood 88: 429–436.
40. Shah AJ, Smogorzewska EM, Hannum C, Crooks GM (1996) Flt3 ligand
induces proliferation of quiescent human bone marrow CD34+CD382 cells and
maintains progenitor cells in vitro. Blood 87: 3563–3570.
41. Mio H, Kagami N, Yokokawa S, Kawai H, Nakagawa S, et al. (1998) Isolation
and characterization of a cDNA for human, mouse and rat full-length stem cell
growth factor (SCGF), a new member of C-type lectin superfamily. Biochem
Biophy Res Comm 249: 124–129.
42. Hiraoka A, Yano KI, Kagami N, Takeshige K, Mio H, et al. (2001) Stem cell
growth factor: in situ hybridization analysis on the gene expression, molecular
characterization and in vitro proliferative activity of a recombinant preparation
on primitive hematopoietic progenitor cells. Hematol J 2: 307–315.
Self-Renewal Potential of Donor HSCs
PLOS ONE | www.plosone.org 11 December 2012 | Volume 7 | Issue 12 | e50693
